These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1476005)
41. Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus. Pan CH; Jimenez GS; Nair N; Wei Q; Adams RJ; Polack FP; Rolland A; Vilalta A; Griffin DE Clin Vaccine Immunol; 2008 Aug; 15(8):1214-21. PubMed ID: 18524884 [TBL] [Abstract][Full Text] [Related]
42. Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge. Putnak R; Feighny R; Burrous J; Cochran M; Hackett C; Smith G; Hoke C Am J Trop Med Hyg; 1991 Aug; 45(2):159-67. PubMed ID: 1877710 [TBL] [Abstract][Full Text] [Related]
43. Measles virus fusion protein- and hemagglutinin-transfected cell lines are a sensitive tool for the detection of specific antibodies by a FACS-measured immunofluorescence assay. de Swart RL; Vos HW; UytdeHaag FG; Osterhaus AD; van Binnendijk RS J Virol Methods; 1998 Mar; 71(1):35-44. PubMed ID: 9628219 [TBL] [Abstract][Full Text] [Related]
44. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection. Schlereth B; Germann PG; ter Meulen V; Niewiesk S J Gen Virol; 2000 May; 81(Pt 5):1321-5. PubMed ID: 10769075 [TBL] [Abstract][Full Text] [Related]
45. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies. Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158 [TBL] [Abstract][Full Text] [Related]
46. Expression of SLAM (CDw150) on Sf9 cell surface using recombinant baculovirus mediates measles virus infection in the nonpermissive cells. Liu X; Zhou W; Zhang P; Xu Q; Hu C; Chen X; Yao L; Li L; Qi Y Microbes Infect; 2005; 7(11-12):1235-45. PubMed ID: 16198138 [TBL] [Abstract][Full Text] [Related]
47. Importance of the cytoplasmic tails of the measles virus glycoproteins for fusogenic activity and the generation of recombinant measles viruses. Moll M; Klenk HD; Maisner A J Virol; 2002 Jul; 76(14):7174-86. PubMed ID: 12072517 [TBL] [Abstract][Full Text] [Related]
48. Previously unrecognized amino acid substitutions in the hemagglutinin and fusion proteins of measles virus modulate cell-cell fusion, hemadsorption, virus growth, and penetration rate. Okada H; Itoh M; Nagata K; Takeuchi K J Virol; 2009 Sep; 83(17):8713-21. PubMed ID: 19553316 [TBL] [Abstract][Full Text] [Related]
50. Expression of cauliflower mosaic virus gene I in insect cells using a novel polyhedrin-based baculovirus expression vector. Zuidema D; Schouten A; Usmany M; Maule AJ; Belsham GJ; Roosien J; Klinge-Roode EC; van Lent JW; Vlak JM J Gen Virol; 1990 Oct; 71 ( Pt 10)():2201-9. PubMed ID: 2230725 [TBL] [Abstract][Full Text] [Related]
51. Synthesis of biologically active influenza virus hemagglutinin in insect larvae. Kuroda K; Gröner A; Frese K; Drenckhahn D; Hauser C; Rott R; Doerfler W; Klenk HD J Virol; 1989 Apr; 63(4):1677-85. PubMed ID: 2648023 [TBL] [Abstract][Full Text] [Related]
52. High level expression of the two outer capsid proteins of bluetongue virus serotype 10: their relationship with the neutralization of virus infection. Marshall JJ; Roy P Virus Res; 1990 Mar; 15(3):189-95. PubMed ID: 2160763 [TBL] [Abstract][Full Text] [Related]
53. Temperature dependent characteristics of a recombinant infectious hematopoietic necrosis virus glycoprotein produced in insect cells. Cain KD; Byrne KM; Brassfield AL; LaPatra SE; Ristow SS Dis Aquat Organ; 1999 Apr; 36(1):1-10. PubMed ID: 10349547 [TBL] [Abstract][Full Text] [Related]
54. Expression of measles virus antigens in Streptococcus gordonii. Maggi T; Oggioni MR; Medaglini D; Bianchi Bandinelli ML; Soldateschi D; Wiesmüller KH; Muller CP; Valensin PE; Pozzi G New Microbiol; 2000 Apr; 23(2):119-28. PubMed ID: 10872681 [TBL] [Abstract][Full Text] [Related]
55. C3d enhancement of neutralizing antibodies to measles hemagglutinin. Green TD; Newton BR; Rota PA; Xu Y; Robinson HL; Ross TM Vaccine; 2001 Oct; 20(1-2):242-8. PubMed ID: 11567770 [TBL] [Abstract][Full Text] [Related]
57. Synthesis of the virus-specified tubules of epizootic haemorrhagic disease virus using a baculovirus expression system. Nel LH; Huismans H Virus Res; 1991 May; 19(2-3):139-52. PubMed ID: 1891959 [TBL] [Abstract][Full Text] [Related]
58. Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Rota JS; Wang ZD; Rota PA; Bellini WJ Virus Res; 1994 Mar; 31(3):317-30. PubMed ID: 8191786 [TBL] [Abstract][Full Text] [Related]
59. A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism. Johnston IC; ter Meulen V; Schneider-Schaulies J; Schneider-Schaulies S J Virol; 1999 Aug; 73(8):6903-15. PubMed ID: 10400788 [TBL] [Abstract][Full Text] [Related]
60. The phosphoprotein of attenuated measles AIK-C vaccine strain contributes to its temperature-sensitive phenotype. Komase K; Nakayama T; Iijima M; Miki K; Kawanishi R; Uejima H Vaccine; 2006 Feb; 24(6):826-34. PubMed ID: 16140429 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]